Literature DB >> 30482313

Parkinson disease.

Samuel D Kim1, Natalie E Allen2, Colleen G Canning2, Victor S C Fung3.   

Abstract

Parkinson disease (PD) is a complex, multisystem disorder with both neurologic and systemic nonmotor manifestations. It is neurodegenerative in nature in which disordered balance, gait, and falls are universal problems that can be present at initial diagnosis, and which progress over time. Freezing of gait is a particularly debilitating feature of PD that becomes more prevalent over time with disease progression, being present in approximately 7% after 2 years of disease and 28% after 5 years. Approximately 60% of people with PD fall each year, with around 70% of fallers falling recurrently, and some recurrent fallers falling multiple times per week. Many risk factors for falls in people with PD have been identified; these include a history of falls, freezing of gait, and abnormalities in measures of balance, leg muscle strength, mobility, cognition, and fear of falling. Therapies for improving physical function and mobility include levodopa, cholinesterase inhibitors, methylphenidate, deep-brain stimulation, cuing for freezing of gait, and exercise. This chapter reviews the clinical, pathologic, and physiologic correlates of gait disturbance and falls in PD, as well as the evidence for medical and nonmedical interventions.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Parkinson disease; accidental falls; balance; exercise; gait; medical and nonmedical interventions

Mesh:

Year:  2018        PMID: 30482313     DOI: 10.1016/B978-0-444-63916-5.00011-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  7 in total

1.  The relation between falls risk and movement variability in Parkinson's disease.

Authors:  Steven Morrison; Jacquelyn Moxey; Nick Reilly; Daniel M Russell; Karen M Thomas; Alex A Grunsfeld
Journal:  Exp Brain Res       Date:  2021-04-29       Impact factor: 1.972

Review 2.  Primary cilia and ciliary signaling pathways in aging and age-related brain disorders.

Authors:  Rong Ma; Naseer A Kutchy; Liang Chen; Douglas D Meigs; Guoku Hu
Journal:  Neurobiol Dis       Date:  2021-12-31       Impact factor: 7.046

3.  Istradefylline Versus Opicapone for "Off" Episodes in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Alok Singh; Dhyuti Gupta; Suryaprakash Dhaneria; Pranav G Sheth
Journal:  Ann Neurosci       Date:  2021-10-05

Review 4.  Cerebrospinal Fluid Metabolome in Parkinson's Disease and Multiple System Atrophy.

Authors:  Do Hyeon Kwon; Ji Su Hwang; Seok Gi Kim; Yong Eun Jang; Tae Hwan Shin; Gwang Lee
Journal:  Int J Mol Sci       Date:  2022-02-07       Impact factor: 5.923

Review 5.  Marine Biocompounds for Neuroprotection-A Review.

Authors:  Adrian Florian Bălașa; Cristina Chircov; Alexandru Mihai Grumezescu
Journal:  Mar Drugs       Date:  2020-05-31       Impact factor: 5.118

Review 6.  Fifteen Years of Wireless Sensors for Balance Assessment in Neurological Disorders.

Authors:  Alessandro Zampogna; Ilaria Mileti; Eduardo Palermo; Claudia Celletti; Marco Paoloni; Alessandro Manoni; Ivan Mazzetta; Gloria Dalla Costa; Carlos Pérez-López; Filippo Camerota; Letizia Leocani; Joan Cabestany; Fernanda Irrera; Antonio Suppa
Journal:  Sensors (Basel)       Date:  2020-06-07       Impact factor: 3.576

Review 7.  Membrane Interactions and Toxicity by Misfolded Protein Oligomers.

Authors:  Mario Gonzalez-Garcia; Giuliana Fusco; Alfonso De Simone
Journal:  Front Cell Dev Biol       Date:  2021-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.